Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes far beyond the annotations by disclosing detailed behaviors: graceful degradation if GLEIF/OpenFIGI is unavailable, assertion of nothing and return of figi_candidates when ambiguous, explicit listing of unresolved identifiers under 'unresolved', and internal cascading through lookups. These are valuable behavioral traits not inferable from readOnlyHint or idempotentHint.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but information-dense; each sentence adds locally relevant context for a complex entity-resolving tool. It is front-loaded with examples and high-level purpose, then details. While some redundancy exists (e.g., repeated mentions of FIGI), overall it earns its length given the tool's complexity, but it could be tightened slightly without losing value.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The description fully covers what an agent needs to know to call the tool correctly: input formats, supported types, behavioral on ambiguity, graceful degradation, and how different identifiers are sourced. Since there is no output schema, the description adequately explains return-like concepts (figi_candidates, unresolved), and annotations already cover safety. Nothing critical is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds substantial meaning beyond the schema. For the 'value' parameter, it provides crucial guidance about passing only the entity name and warns against including security-class words like 'revenue bonds' with a concrete example. It also explains how ISIN input resolves via the GLEIF mapping, enriching the semantics beyond the schema's brief text.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states that the tool resolves a user-spoken name to canonical/official identifiers, which is a specific verb and resource. It enumerates the supported types (company, drug) and explicitly mentions cross-source identifiers (CIK, ticker, LEI, FIGI, RxCUI), distinguishing it from siblings. It also notes the specific use case of resolving names to IDs that other tools require.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID', which is clear when-to-use guidance. It also explains that it replaces multiple manual lookups. However, it does not explicitly mention when not to use it or name alternative sibling tools (like entity_profile) for other purposes, so it lacks full when-not/alternatives coverage.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation2/5

The tools span vastly different domains (AI visibility, data querying, prediction markets, GIS) with clear descriptions individually, but the set lacks a coherent focus. An agent looking for ArcGIS functionality would be distracted by many unrelated tools, causing confusion in tool selection.

Naming Consistency2/5

Most tool names use snake_case, but there is no consistent verb_noun pattern. Some names are verbs (remember, forget), others are noun phrases (entity_profile, layer_info), and some include underscores inconsistently (generate_llms_txt vs. bet_research). The naming feels arbitrary.

Tool Count1/5

With 33 tools, the count is high, but the vast majority are from Pipeworx and unrelated to the server's stated purpose (Arcgis Roanoke). Only 3-4 tools actually relate to GIS. The tool count is extremely inappropriate for the server's focus.

Completeness1/5

For the implied domain of ArcGIS Roanoke, the tool surface is severely incomplete, lacking CRUD for map layers, spatial queries, or data management. Conversely, the Pipeworx subset is also incomplete on its own (e.g., missing many data sources). The overall surface fails to serve any single domain well.